It is proposed to redirect somewhat the focus of the Integrated Microscopy Resource as a national center with the instrumentation, skills and knowledge for the application of light and electron microscope techniques to the study of live cells and tissues. There will be two main areas of core research. The first is a new thrust focusing on the development of optical instrumentation for the study of live cells and tissues. The second is the extension of previous work focusing on the development of sample preparation techniques for correlative electron microscopy. The optical workstation will have facilities for recording time-lapse sequences of events in multiple planes. It will also have facilities for the manipulation of organelles by optical trapping, photobleaching, photoactivation, laser ablation and patterned irradiation. A major design goal will be to develop an economical system that is easy to use. The design detail of the workstation will be driven by biological applications. One of the main objectives for the work on sample preparation techniques for electron microscopy would be the development of correlative light microscopy and EM analysis of the same specimen. In addition to the deembedding technique developed by the IMR, protocols will be developed for rapidly demounting individual samples from the light microscope for cryofixation. Also, new metal-coating techniques of frozen-hydrated or controlled freeze-dried specimens will be developed for high resolution FESEM. It is proposed to acquire a JEOL 4000FX Intermediate Voltage Electron Microscope with electronic image capture in place of the current High Voltage Electron Microscope that is to be decommissioned. Digitally captured electron micrographs will obviate the need for the time-consuming production of a large number of photographic negatives and prints for serial-section reconstructions. A software system for manipulating and archiving images will be developed for both light and electron microscopy. In addition, the IVEM would have allowed relatively thick sections (up to 0.5 micrometer) to be used for serial reconstructions.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
3P41RR000570-28S1
Application #
2730824
Study Section
Special Emphasis Panel (ZRG7-SRB (01))
Project Start
1974-12-01
Project End
2000-06-30
Budget Start
1998-09-30
Budget End
2000-06-30
Support Year
28
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Biochemistry
Type
Other Domestic Higher Education
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Malecki, Marek; Putzer, Emily; Sabo, Chelsea et al. (2014) Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies. Mol Cell Ther 2:
Malecki, Marek (2014) 'Above all, do no harm': safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis. Stem Cell Res Ther 5:73
Mavroudi, Maria; Zarogoulidis, Paul; Porpodis, Konstantinos et al. (2014) Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy. J Cancer Res Ther (Manch) 2:22-33
Malecki, Marek; LaVanne, Christine; Alhambra, Dominique et al. (2013) Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of DNASE1, DNASE1L3, DNASE2, DFFB Controlled By POLA1 Promoter in Proliferating and Directed Differentiation Resisting Human Autologous Pluripotent J Stem Cell Res Ther Suppl 9:
Malecki, Marek; Tombokan, Xenia; Anderson, Mark et al. (2013) TRA-1-60(+), SSEA-4(+), POU5F1(+), SOX2(+), NANOG(+) Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Testes. J Stem Cell Res Ther 3:
Malecki, Marek (2013) Improved targeting and enhanced retention of the human, autologous, fibroblast-derived, induced, pluripotent stem cells to the sarcomeres of the infarcted myocardium with the aid of the bioengineered, heterospecific, tetravalent antibodies. J Stem Cell Res Ther 3:
Malecki, Marek; Dahlke, Jessica; Haig, Melissa et al. (2013) Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer. J Genet Syndr Gene Ther 4:152
Zarogoulidis, Paul; Darwiche, Kaid; Sakkas, Antonios et al. (2013) Suicide Gene Therapy for Cancer - Current Strategies. J Genet Syndr Gene Ther 4:
Malecki, Marek; Sabo, Chelsea; Putzer, Emily et al. (2013) Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration. Mol Cell Ther 1:
Malecki, Marek; Malecki, Bianca (2012) Routing of Biomolecules and Transgenes' Vectors in Nuclei of Oocytes. J Fertili In Vitro 2012:108-118

Showing the most recent 10 out of 24 publications